Did you catch Ginflex®'s Symposium at the
Singapore Orthopaedic Association (SOA)
46th Annual Scientific Meeting?
At the recent Singapore Orthopaedic Association (SOA) 2024 Conference, Ginflex® hosted an insightful symposium led by Assoc. Professor Joyce Koh (Senior Consultant, SGH) and Adj. Asst. Professor Barry Tan (Consultant, NUH). The session, entitled "Addressing Unmet Needs in Orthopaedics: Latest Innovations & Clinical Evidence of Ginflex®", focused on the global Arthritis crisis and how Ginflex® fulfils the criteria of an ideal health supplement that slows disease progression as well as manages joint pain & inflammation quickly in just 5 to 7 days!
Click on the video to hear how the symposium went!
Ginflex® Presented as the Ideal Supplement for Arthritis:
Supported by scientific evidence showing efficacy & safety
Fast onset of action in 5 to 7 days
-
Provides quick relief of pain & inflammation, improves joint function in 5 to 7 days
Established safety profile
-
Safety parameters i.e. serum, hematology, urine labs evaluated in RCTs remained within normal laboratory range with no adverse effects
Reduces need for formal analgesia including Paracetamol & NSAIDs
Convenient once daily dosing
Culturally well-accepted & appropriate for diverse patient groups
-
Halal-certified, suitable for Muslims
-
100% plant-based, suitable for vegetarians & vegans
Continuous advancements in research with new clinical data
-
Confidential preview RCT demonstrates continuous improvement in pain, stiffness, physical function & cartilage health even over 6 months